See more : Vivos Therapeutics, Inc. (VVOS) Income Statement Analysis – Financial Results
Complete financial analysis of Nexstim Plc (NXTMH.HE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nexstim Plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- Rubis (RBSFY) Income Statement Analysis – Financial Results
- JPMorgan American Investment Trust plc (JAM.L) Income Statement Analysis – Financial Results
- KGI Securities (Thailand) Public Company Limited (KGI.BK) Income Statement Analysis – Financial Results
- Fagron NV (ARSUF) Income Statement Analysis – Financial Results
- Constellation Brands, Inc. (STZ-B) Income Statement Analysis – Financial Results
Nexstim Plc (NXTMH.HE)
About Nexstim Plc
Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.25M | 9.53M | 6.40M | 4.11M | 3.35M | 2.67M | 2.65M | 2.48M | 2.53M | 2.21M | 1.87M | 3.19M |
| Cost of Revenue | 4.93M | 5.16K | 177.02K | 969.31K | 1.05M | 1.03M | 2.03M | 1.82M | 4.48M | 2.70M | 627.68K | 750.82K |
| Gross Profit | 2.31M | 9.52M | 6.22M | 3.14M | 2.30M | 1.64M | 614.19K | 666.80K | -1.95M | -494.03K | 1.24M | 2.44M |
| Gross Profit Ratio | 31.91% | 99.95% | 97.23% | 76.44% | 68.75% | 61.28% | 23.22% | 26.86% | -77.05% | -22.35% | 66.45% | 76.47% |
| Research & Development | 1.00M | 753.53K | 884.01K | 368.27K | 559.65K | 571.63K | 347.95K | 164.70K | 241.37K | 396.29K | 509.09K | 0.00 |
| General & Administrative | 2.24M | 1.05M | 1.21M | 544.31K | 956.87K | 502.57K | 923.06K | 528.30K | 1.24M | 1.20M | 112.00 | 1.11K |
| Selling & Marketing | 274.79K | 237.66K | 148.38K | 144.60K | 321.87K | 302.40K | 215.09K | 206.25K | 203.35K | 344.95K | 212.71K | 0.00 |
| SG&A | 2.51M | 1.29M | 1.35M | 688.91K | 1.28M | 804.97K | 1.14M | 734.54K | 1.44M | 1.55M | 112.00 | 1.11K |
| Other Expenses | 0.00 | 6.64M | 5.43M | 5.42M | 6.98M | 6.58M | 4.72M | 6.46M | 6.74M | 5.36M | 5.68M | 5.06M |
| Operating Expenses | 3.52M | 8.68M | 7.67M | 6.48M | 8.82M | 7.95M | 6.21M | 7.36M | 8.42M | 7.31M | 5.68M | 5.06M |
| Cost & Expenses | 8.45M | 8.69M | 7.85M | 7.45M | 9.87M | 8.99M | 8.24M | 9.18M | 12.90M | 10.01M | 6.31M | 5.81M |
| Interest Income | 61.36K | 545.83K | 2.01M | 1.94M | 1.29M | 858.14K | 382.60 | 134.05 | 1.93M | 327.85K | 397.51 | 2.48K |
| Interest Expense | 144.60K | 54.95K | 1.30M | 2.76M | 1.55M | 695.09K | 1.73M | 34.48K | 1.39M | 2.97M | 80.60K | 83.75K |
| Depreciation & Amortization | 242.58K | 248.52K | 280.45K | 337.83K | 487.76K | 388.87K | 341.30K | 372.32K | 386.00K | 377.40K | 237.70K | 305.90K |
| EBITDA | -935.51K | 1.61M | 842.65K | -1.06M | -4.74M | -5.07M | -5.25M | -6.32M | -8.05M | -7.09M | -4.20M | -2.31M |
| EBITDA Ratio | -12.91% | 19.56% | 15.72% | -24.16% | -140.58% | -188.37% | -198.47% | -254.72% | -318.56% | -320.95% | -224.32% | -72.46% |
| Operating Income | -1.19M | 1.37M | 657.54K | -3.33M | -6.52M | -6.32M | -5.59M | -6.70M | -10.37M | -7.80M | -4.43M | -2.62M |
| Operating Income Ratio | -16.47% | 14.34% | 10.28% | -81.01% | -194.66% | -236.35% | -211.39% | -269.72% | -410.21% | -352.85% | -237.02% | -82.05% |
| Total Other Income/Expenses | -129.24K | -54.95K | -1.39M | -783.92K | -259.47K | 163.04K | -1.73M | -34.35K | 544.05K | -2.65M | -80.21K | -81.27K |
| Income Before Tax | -1.32M | 1.31M | -733.25K | -4.12M | -6.78M | -6.15M | -7.33M | -6.73M | -9.83M | -10.45M | -4.51M | -2.70M |
| Income Before Tax Ratio | -18.25% | 13.77% | -11.46% | -100.07% | -202.41% | -230.25% | -276.91% | -271.10% | -388.69% | -472.55% | -241.31% | -84.60% |
| Income Tax Expense | 4.83K | 4.53K | 98.85K | 4.98K | 5.72K | 1.73K | 2.80K | 2.30K | 1.38K | 2.65M | 80.21K | 81.27K |
| Net Income | -1.33M | 1.31M | -832.11K | -4.12M | -6.78M | -6.15M | -7.33M | -6.73M | -9.83M | -10.45M | -4.51M | -2.70M |
| Net Income Ratio | -18.32% | 13.72% | -13.01% | -100.19% | -202.58% | -230.31% | -277.01% | -271.20% | -388.75% | -472.55% | -241.31% | -84.60% |
| EPS | -0.20 | 0.20 | -0.14 | -1.21 | -4.67 | -26.51 | -9.01 | -55.03 | -134.15 | -231.53 | -93.39 | -55.82 |
| EPS Diluted | -0.20 | 0.18 | -0.14 | -1.21 | -4.67 | -26.51 | -6.24 | -41.72 | -120.86 | -211.41 | -93.39 | -55.82 |
| Weighted Avg Shares Out | 6.64M | 6.70M | 6.07M | 3.42M | 1.45M | 232.18K | 813.69K | 122.35K | 73.25K | 45.11K | 48.35K | 48.35K |
| Weighted Avg Shares Out (Dil) | 6.64M | 7.28M | 6.07M | 3.42M | 1.45M | 232.18K | 1.17M | 161.38K | 81.31K | 49.41K | 48.35K | 48.35K |
Source: https://incomestatements.info
Category: Stock Reports